Price: quote on request. Your total cost is quoted in writing per case.
We reply within one business day
Get my quote

Narcolepsy: US-approved treatments and how Gulf families can access them

A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Narcolepsy: the short answer

The US FDA has approved four medicines on this page for narcolepsy, each for specific patients. One of them is on at least one Gulf register we checked, so ask your hospital about local supply first. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.

  • US FDA-approved medicines on this page: Wakix, Xywav, Lumryz and Sunosi.
  • Gulf registration (checked 17 October 2026): see each medicine below.
  • Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital.
  • Price: Quote on request.

What is narcolepsy?

Narcolepsy is a long-term sleep disorder that disrupts the normal sleep-wake cycle. It most often begins in adolescence. The main feature is excessive daytime sleepiness, with sudden urges to sleep that can happen during a meal or a conversation.[1]

Many people also have cataplexy, a sudden loss of muscle tone triggered by strong emotions such as laughing, surprise or anger, which can make a person slump or fall. Night sleep is often broken, and vivid hallucinations or sleep paralysis can occur when falling asleep or waking up.[1]

Narcolepsy is one of the hypersomnias, a group of sleep disorders with extreme daytime sleepiness. Diagnosis is made by a sleep specialist. In the US, several medicines are approved to treat daytime sleepiness and, for some, cataplexy.[2, 3, 4]

Narcolepsy in the Gulf

Two Saudi referral sleep centers identified 173 patients with narcolepsy and found no increase in new cases after the 2009 H1N1 influenza vaccine was introduced, with most patients (83%) reporting symptoms that began before June 2009.[5]

US FDA-approved medicines for narcolepsy

Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.

  • Wakix (pitolisant hydrochloride)
    FDA-approved for excessive daytime sleepiness or cataplexy in patients 6 years and older with narcolepsy. It is a tablet taken once a day.[3]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
  • Xywav (calcium, magnesium, potassium, and sodium oxybates)
    FDA-approved for cataplexy or excessive daytime sleepiness in patients 7 years and older with narcolepsy. It is an oral solution taken at night. It is also approved for idiopathic hypersomnia in adults.[4]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
  • Lumryz (sodium oxybate)
    FDA-approved for cataplexy or excessive daytime sleepiness in patients 7 years and older with narcolepsy. It is an extended-release powder for suspension taken once at bedtime.[8]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
  • Sunosi (solriamfetol)
    FDA-approved for improving wakefulness in adults with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. It is a tablet.[9]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]

How families in the Gulf can access these medicines

If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, and another brand of the same medicine may also be registered, but local supply is usually the fastest route and you may not need us.

If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.[10, 11] Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.

Who does what

  • Your treating specialist decides whether a medicine is right for the patient and writes the letter.
  • The hospital checks local supply, files any import request, and gives the treatment safely.
  • The national regulator decides whether to approve the import of a medicine that is not registered.
  • The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
  • Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents you will usually need

  • A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
  • Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
  • Recent clinic notes and a list of current medicines
  • For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
  • Proof of the US FDA approval and the US prescribing information (we can supply these)

We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.

What treatment costs

Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.

Ask us about treatment for narcolepsy

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Include the country code, for example +966 or +971.
Message us on WhatsApp

No account needed. We reply within one business day. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Frequently asked questions

Is there an FDA-approved treatment for narcolepsy?

Yes. The medicines on this page have US FDA approval for specific groups of patients: Wakix, Xywav, Lumryz and Sunosi. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.

Is Wakix available in Saudi Arabia or the UAE?

Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.

How can a family in the Gulf get Wakix?

Ask the treating hospital about local supply first. If it is not available, the hospital can file a named-patient import request with the national regulator on your specialist's written request. Once approved, we arrange US supply to the hospital pharmacy.

How much does treatment cost?

Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

What is cataplexy?

It is a sudden, brief loss of muscle tone triggered by strong emotions such as laughter or surprise. MedlinePlus Genetics notes that most people diagnosed with narcolepsy also have cataplexy.

Are oxybate medicines easy to import?

Oxybate medicines are tightly controlled in many countries. Importing a controlled medicine needs extra permits from the national regulator, so your hospital pharmacy must confirm whether it is possible before anything else.

Sources for the last two answers: [1] [4]

Sources

Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.

  1. MedlinePlus Genetics (US National Library of Medicine): Narcolepsy
  2. MedlinePlus (US National Library of Medicine): Sleep Disorders
  3. DailyMed (US National Library of Medicine): Wakix (pitolisant hydrochloride) US prescribing information, version published 26 February 2026
  4. DailyMed (US National Library of Medicine): Xywav (calcium, magnesium, potassium, and sodium oxybates) US prescribing information, version published 17 November 2025
  5. Qasrawi et al. Narcolepsy in Saudi patients before and after the 2009 H1N1 vaccination. The experience of 2 referral centers. Saudi Med J 2017 (PubMed 29209667)
  6. SFDA: Drugs List, public register (all 9,173 entries checked by brand name on 17 October 2026)
  7. Department of Health Abu Dhabi: drug code list Drugs.xlsx (release 26 September 2026, effective 2 October 2026)
  8. DailyMed (US National Library of Medicine): Lumryz (sodium oxybate) US prescribing information, version published 17 September 2026
  9. DailyMed (US National Library of Medicine): Sunosi (solriamfetol) US prescribing information, version published 11 May 2026
  10. SFDA: Special Access Program (SAP) guidance, version 1.0
  11. NHRA Bahrain: Circular No. (41) of 2020, procedures for importing non-registered medicines and pharmaceutical products

Related

This page is general health information, not medical advice. It does not replace a consultation with your doctor.

WhatsApp